Supplements
More than 5% of individuals in the United States are diagnosed with schizophrenia or bipolar disorder; these conditions can have a significant impact on health economics and personal productivity. For example, schizophrenia often results in unemployment and is considered a major cause of long-term disability worldwide. According to a recent study, the indirect costs attributed to schizophrenia between 2005 and 2008 totaled approximately $75 billion.

Download PDF
Last modified: January 6, 2016
  • American Health & Drug Benefits
  • The Journal of Hematology Oncology Pharmacy
  • Lynx CME
  • The Oncology Pharmacist

Search